
Biocon Limited has informed the Exchange regarding a press release dated March 06, 2025, titled "Biocon Biologics and Civica, Inc. Collaborate to ExpandInsulin Aspart Access in the United States".
Filed with NSE ·

Biocon Limited has informed the Exchange regarding a press release dated March 06, 2025, titled "Biocon Biologics and Civica, Inc. Collaborate to ExpandInsulin Aspart Access in the United States".
6ix hasn’t read this filing yet.
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon